Verenium Corporation VRNM, a
leading industrial biotechnology company focused on the development and
commercialization of high-performance enzymes, today announced the commercial
launch of Pyrolase^® HT cellulase, a next-generation cellulase enzyme for use
as a biocatalyst to break down the guar-based gel used in hydraulic
fracturing.
(Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO)
Pyrolase^® HT is a highly thermo-stable enzyme developed by Verenium
scientists using proprietary DirectEvolution^® technology to meet more
demanding performance requirements and expand the addressable market that can
be serviced by its product line.
In July 2012, Verenium announced that the Company had received regulatory
authorization from the Environmental Protection Agency (EPA) to market
Pyrolase^® HT cellulase. In laboratory evaluations conducted by several
oilfield service companies, it has demonstrated that it functions well in more
extreme temperature ranges and higher pH conditions.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in